BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 29705220)

  • 1. Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY Trial.
    Chin KM; Gomberg-Maitland M; Channick RN; Cuttica MJ; Fischer A; Frantz RP; Hunsche E; Kleinman L; McConnell JW; McLaughlin VV; Miller CE; Zamanian RT; Zastrow MS; Badesch DB
    Chest; 2018 Oct; 154(4):848-861. PubMed ID: 29705220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
    McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
    Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients.
    Bonner N; Abetz L; Meunier J; Sikirica M; Mathai SC
    Health Qual Life Outcomes; 2013 Oct; 11():161. PubMed ID: 24088389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire Short Form (HIS-Q-SF).
    Gelhorn HL; Roberts LJ; Khandelwal N; Revicki DA; DeRogatis LR; Dobs A; Hepp Z; Miller MG
    J Sex Med; 2017 Aug; 14(8):1046-1058. PubMed ID: 28760247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary.
    Kawata AK; Hsieh R; Bender R; Shaffer S; Revicki DA; Bayliss M; Buse DC; Desai P; Sapra S; Ortmeier B; Hareendran A
    Headache; 2017 Oct; 57(9):1385-1398. PubMed ID: 28857154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire.
    Reis A; Twiss J; Vicente M; Gonçalves F; Carvalho L; Meireles J; Melo A; McKenna SP; Almeida L
    Health Qual Life Outcomes; 2016 Jul; 14(1):110. PubMed ID: 27460644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the psychometric properties of the Early Morning Symptoms of COPD Instrument (EMSCI).
    Hareendran A; Make BJ; Zaiser E; Garcia Gil E
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1633-1645. PubMed ID: 29849455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the psychometric properties of the Nighttime Symptoms of COPD Instrument.
    Mocarski M; Zaiser E; Trundell D; Make BJ; Hareendran A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():475-87. PubMed ID: 25834415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire.
    Gelhorn HL; Dashiell-Aje E; Miller MG; DeRogatis LR; Dobs A; Seftel AD; Althof SE; Brod M; Revicki DA
    J Sex Med; 2016 Nov; 13(11):1737-1749. PubMed ID: 27692845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial.
    Mehta S; Sastry BKS; Souza R; Torbicki A; Ghofrani HA; Channick RN; Delcroix M; Pulido T; Simonneau G; Wlodarczyk J; Rubin LJ; Jansa P; Hunsche E; Galiè N; Perchenet L; Sitbon O
    Chest; 2017 Jan; 151(1):106-118. PubMed ID: 27671974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).
    Alexander M; Berger W; Buchholz P; Walt J; Burk C; Lee J; Arbuckle R; Abetz L
    Health Qual Life Outcomes; 2005 Oct; 3():67. PubMed ID: 16259630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported outcome domains for the esophageal CONDUIT report card: a prospective trial to establish domains.
    Lee MK; Yost KJ; Pierson KE; Blackmon SH
    Health Qual Life Outcomes; 2018 Oct; 16(1):197. PubMed ID: 30305083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the impact on caregivers of patients with schizophrenia: psychometric validation of the Schizophrenia Caregiver Questionnaire (SCQ).
    Rofail D; Regnault A; le Scouiller S; Lambert J; Zarit SH
    BMC Psychiatry; 2016 Jul; 16():245. PubMed ID: 27431493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric Evaluation of a New Patient-Reported Outcome (PRO) Symptom Diary for Varicose Veins: VVSymQ(®) Instrument.
    Wright DD; Paty J; Turner-Bowker DM; Bradbury A
    Patient; 2016 Aug; 9(4):335-48. PubMed ID: 27016239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension.
    McKenna SP; Doughty N; Meads DM; Doward LC; Pepke-Zaba J
    Qual Life Res; 2006 Feb; 15(1):103-15. PubMed ID: 16411035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceived subject outcomes and impact on health-related quality of life associated with diet using the new Food Benefits Assessment (FBA) questionnaire: development and psychometric validation.
    Guyonnet D; Chassany O; Picard C; Guillemin I; Meunier J; Seignobos E; Vigneux M; Lassel T; Trudeau E
    Public Health Nutr; 2008 Nov; 11(11):1163-72. PubMed ID: 18279564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric properties of the FACT-M questionnaire in patients with Merkel cell carcinoma.
    Bharmal M; Fofana F; Barbosa CD; Williams P; Mahnke L; Marrel A; Schlichting M
    Health Qual Life Outcomes; 2017 Dec; 15(1):247. PubMed ID: 29273043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial.
    Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL
    Clin Ther; 2007 May; 29(5):950-962. PubMed ID: 17697914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity and test retest reliability of the vascular quality of life Questionnaire-6: a short form of a disease-specific health-related quality of life instrument for patients with peripheral arterial disease.
    Kumlien C; Nordanstig J; Lundström M; Pettersson M
    Health Qual Life Outcomes; 2017 Sep; 15(1):187. PubMed ID: 28962624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and psychometric evaluation of the ICIQ Vaginal Symptoms Questionnaire: the ICIQ-VS.
    Price N; Jackson SR; Avery K; Brookes ST; Abrams P
    BJOG; 2006 Jun; 113(6):700-12. PubMed ID: 16709214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.